KPC Pharmaceuticals appoints He Ming as vice president
KPC Pharmaceuticals Inc. (SSE:600422) announced the appointment of He Ming as Vice President, as approved during the company's Eleventh Board of Directors' Sixth Meeting on June 23, 2025. The appointment follows a review by the Nomination Committee and is effective from the date of the board's approval, lasting until the end of the term of the Eleventh Board of Directors. He Ming previously held positions at China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. and KPC Pharmaceuticals, including roles in marketing, OTC business, and as the company's Discipline Inspection Secretary. The company affirms that He Ming meets all qualifications and compliance requirements as stipulated by relevant laws and regulations. He Ming does not hold any shares in the company, has no conflicts of interest with other directors, supervisors, or senior management, and has not been subject to penalties from regulatory bodies.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when KPC Pharmaceuticals Inc publishes news
Free account required • Unsubscribe anytime